Nonmyeloid Malignancies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2022-05-26
FDA Approved: FYLNETRA — Original Application (Amneal Pharmaceuticals LLC)
FDA approves FYLNETRA (pegfilgrastim) from Amneal as an original biologics license application to help reduce the duration of neutropenia in…